Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alvotech (ALVO) Gains from Sales and Divestitures (2023 - 2025)

Alvotech filings provide 3 years of Gains from Sales and Divestitures readings, the most recent being $184000.0 for Q3 2025.

  • On a quarterly basis, Gains from Sales and Divestitures changed 0.0% to $184000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $184000.0, a 0.0% change, with the full-year FY2023 number at $365000.0, changed N/A from a year prior.
  • Gains from Sales and Divestitures hit $184000.0 in Q3 2025 for Alvotech, roughly flat from $184000.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $323000.0 in Q2 2023 to a low of $184000.0 in Q3 2024.
  • Median Gains from Sales and Divestitures over the past 3 years was $184000.0 (2024), compared with a mean of $230333.3.
  • The widest YoY moves for Gains from Sales and Divestitures: up 0.0% in 2025, down 0.0% in 2025.
  • Alvotech's Gains from Sales and Divestitures stood at $323000.0 in 2023, then plummeted by 43.03% to $184000.0 in 2024, then changed by 0.0% to $184000.0 in 2025.
  • The last three reported values for Gains from Sales and Divestitures were $184000.0 (Q3 2025), $184000.0 (Q3 2024), and $323000.0 (Q2 2023) per Business Quant data.